ALLO vs ASML · rev $22.0K vs P/E 57, $665.37B cap
Allogene Therapeutics Inc (ALLO) versus ASML Holding NV ADR (ASML) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
ASML does not have a complete income-statement cache yet.
ALLO currently screens at market cap $258.1M. ASML currently screens at market cap $665.37B and trailing P/E 57.5.
Not investment advice. Open the ALLO and ASML stock pages for the full models.
Not investment advice.